Extending the Coverage of Lys-C/Trypsin-Based Bottom-up Proteomics by Cysteine S-Aminoethylation
Journal of the American Society for Mass Spectrometry · 2024
DOI: 10.1021/jasms.3c00448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2024. Verfasst von Ryota Tomioka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Corporation.
Abstract (Originalsprache)
To improve the coverage in bottom-up proteomics, S-aminoethylation of cysteine residues (AE-Cys) was carried out with 2-bromoethylamine, followed by cleavage with lysyl endopeptidase (Lys-C) or Lys-C/trypsin. A model study with bovine serum albumin showed that the C-terminal side of AE-Cys was successfully cleaved by Lys-C. The frequency of side reactions at amino acids other than Cys was less than that in the case of carbamidomethylation of Cys with iodoacetamide. Proteomic analysis of A549 cell extracts in the data-dependent acquisition mode after AE-Cys modification afforded a greater number of identified protein groups, especially membrane proteins. In addition, label-free quantification of proteins in mouse nonsmall cell lung cancer (NSCLC) tissue in the data-independent acquisition mode after AE-Cys modification showed improved NSCLC pathway coverage and greater reproducibility. Furthermore, the AE-Cys method could identify an epidermal growth factor receptor peptide containing the T790 M mutation site, a well-established lung-cancer-related mutation site that has evaded conventional bottom-up methods. Finally, AE-Cys was found to fully mimic Lys in terms of collision-induced dissociation fragmentation, ion mobility separation, and cleavage by Lys-C/trypsin, except for sulfoxide formation during sample preparation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- Biopharmaceutical Research Division, Shionogi & Co., Ltd., Toyonaka 561-0825, Osaka, Japan.
- Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan.
- Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen N DK-2200, Denmark.
- Thermo Fisher Scientific GmbH, Bremen 28199, Germany.
- Laboratory of Clinical and Analytical Chemistry, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki 567-0085, Osaka, Japan.
ORCID-Profile: Ryota Tomioka, Kosuke Ogata, Hsin-Ju Chan, Li-Yu Chen, Jesper V Olsen, Yu-Ju Chen, Yasushi Ishihama
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Japan Science and Technology Corporation
Zitieren
APA
Tomioka, R., Tomioka, A., Ogata, K., Chan, H. J., Chen, L. Y., Guzman, U. H., Xuan, Y., Olsen, J. V., Chen, Y. J., & Ishihama, Y. (2024). Extending the Coverage of Lys-C/Trypsin-Based Bottom-up Proteomics by Cysteine S-Aminoethylation. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00448
Vancouver
Tomioka R, Tomioka A, Ogata K, Chan HJ, Chen LY, Guzman UH, et al. Extending the Coverage of Lys-C/Trypsin-Based Bottom-up Proteomics by Cysteine S-Aminoethylation. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.3c00448
BibTeX
@article{Tomioka2024,
author = {Tomioka, Ryota and Tomioka, Ayana and Ogata, Kosuke and Chan, Hsin-Ju and Chen, Li-Yu and Guzman, Ulises H and Xuan, Yue and Olsen, Jesper V and Chen, Yu-Ju and Ishihama, Yasushi},
title = {Extending the Coverage of Lys-C/Trypsin-Based Bottom-up Proteomics by Cysteine S-Aminoethylation},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2024},
doi = {10.1021/jasms.3c00448}
}
EUVIMED